Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps

Home » Blog » Novo Nordisk shares plunge 20% after disappointing trial results; Lilly jumps

December 21, 2024December 21, 2024

Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 24% at one point Friday after reporting trial results that missed expectations.

Previous PostA Santa Claus rally could come just in time next week to help stocks end the year on a high noteNext PostDow closes nearly 500 points higher on cooler inflation data, but index posts third straight losing week: Live updates

Latest Articles

This country may have the fastest-growing e-commerce sector ‘on the planet’
How the Federal Reserve’s rate policy affects mortgages
Banking app Dave, back from the brink, is this year’s biggest gainer among financials with 934% surge
Stocks making the biggest moves midday: Novo Nordisk, Mission Produce, Occidental Petroleum and more
CFPB sues JPMorgan Chase, Bank of America and Wells Fargo over Zelle payment fraud
Stocks making the biggest moves premarket: Novo Nordisk, FedEx, Nike, Starbucks, MicroStrategy and more
Warren Buffett’s Berkshire Hathaway scoops up Occidental and other stocks during sell-off
Elon Musk endorses far-right Alternative for Germany party in upcoming election
Bitcoin trades around $97,000, recovers from earlier losses
Tesla reverses losses to turn higher in a volatile week for the EV stock